| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |